258 related articles for article (PubMed ID: 37424223)
1. Novel precision medicine approaches and treatment strategies in hematological malignancies.
Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Östling P; Cavelier L; Fioretos T; Smedby KE
J Intern Med; 2023 Oct; 294(4):413-436. PubMed ID: 37424223
[TBL] [Abstract][Full Text] [Related]
2. [Precision diagnostics and therapy in hematological malignancies].
Hellström Lindberg E; Cavelier L; Cammenga J; Andersson PO; Fioretos T; Rosenquist R
Lakartidningen; 2021 May; 118():. PubMed ID: 33973223
[TBL] [Abstract][Full Text] [Related]
3. Application of precision medicine in clinical routine in haematology-Challenges and opportunities.
Wästerlid T; Cavelier L; Haferlach C; Konopleva M; Fröhling S; Östling P; Bullinger L; Fioretos T; Smedby KE
J Intern Med; 2022 Aug; 292(2):243-261. PubMed ID: 35599019
[TBL] [Abstract][Full Text] [Related]
4. Precision diagnostics in chronic lymphocytic leukemia: Past, present and future.
Mollstedt J; Mansouri L; Rosenquist R
Front Oncol; 2023; 13():1146486. PubMed ID: 37035166
[TBL] [Abstract][Full Text] [Related]
5. [NGS-based multi-gene panel testing in hematological malignancies: diagnosis and prognostic prediction].
Tanigawa T; Kataoka K
Rinsho Ketsueki; 2022; 63(4):294-301. PubMed ID: 35491219
[TBL] [Abstract][Full Text] [Related]
6. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung C; Ma H
Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
[TBL] [Abstract][Full Text] [Related]
7. Current concepts and future directions for hemato-oncologic diagnostics.
Flach J; Shumilov E; Joncourt R; Porret N; Novak U; Pabst T; Bacher U
Crit Rev Oncol Hematol; 2020 Jul; 151():102977. PubMed ID: 32446181
[TBL] [Abstract][Full Text] [Related]
8. Precision diagnostics in lymphomas - Recent developments and future directions.
Mansouri L; Thorvaldsdottir B; Laidou S; Stamatopoulos K; Rosenquist R
Semin Cancer Biol; 2022 Sep; 84():170-183. PubMed ID: 34699973
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma.
Dewald GW
Int J Hematol; 2002 Aug; 76 Suppl 2():65-74. PubMed ID: 12430903
[TBL] [Abstract][Full Text] [Related]
10. Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.
Kurtz SE; Eide CA; Kaempf A; Khanna V; Savage SL; Rofelty A; English I; Ho H; Pandya R; Bolosky WJ; Poon H; Deininger MW; Collins R; Swords RT; Watts J; Pollyea DA; Medeiros BC; Traer E; Tognon CE; Mori M; Druker BJ; Tyner JW
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7554-E7563. PubMed ID: 28784769
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Yasuda T; Sanada M; Nishijima D; Kanamori T; Iijima Y; Hattori H; Saito A; Miyoshi H; Ishikawa Y; Asou N; Usuki K; Hirabayashi S; Kato M; Ri M; Handa H; Ishida T; Shibayama H; Abe M; Iriyama C; Karube K; Nishikori M; Ohshima K; Kataoka K; Yoshida K; Shiraishi Y; Goto H; Adachi S; Kobayashi R; Kiyoi H; Miyazaki Y; Ogawa S; Kurahashi H; Yokoyama H; Manabe A; Iida S; Tomita A; Horibe K
Cancer Sci; 2020 Sep; 111(9):3367-3378. PubMed ID: 32619037
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide arrays in routine diagnostics of hematological malignancies.
Simons A; Sikkema-Raddatz B; de Leeuw N; Konrad NC; Hastings RJ; Schoumans J
Hum Mutat; 2012 Jun; 33(6):941-8. PubMed ID: 22488943
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia.
Lilljebjörn H; Orsmark-Pietras C; Mitelman F; Hagström-Andersson A; Fioretos T
Semin Cancer Biol; 2022 Sep; 84():40-49. PubMed ID: 34606984
[TBL] [Abstract][Full Text] [Related]
14. An overview of genetic predisposition to familial hematological malignancies.
Hamadou WS; Bouali N; Besbes S; Mani R; Bardakci F; Siddiqui AJ; Badraoui R; Adnan M; Sobol H; Soua Z
Bull Cancer; 2021; 108(7-8):718-724. PubMed ID: 34052033
[TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
16. [Precision medicine for acute myeloid leukemia based on genomic profiling].
Sanada M
Rinsho Ketsueki; 2019; 60(7):847-853. PubMed ID: 31391376
[TBL] [Abstract][Full Text] [Related]
17. Current status and trends in the diagnostics of AML and MDS.
Shumilov E; Flach J; Kohlmann A; Banz Y; Bonadies N; Fiedler M; Pabst T; Bacher U
Blood Rev; 2018 Nov; 32(6):508-519. PubMed ID: 29728319
[TBL] [Abstract][Full Text] [Related]
18. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract][Full Text] [Related]
19. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
[TBL] [Abstract][Full Text] [Related]
20. Characterization of leukemias with ETV6-ABL1 fusion.
Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]